Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
Clinical trial NCT05722327 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05722327
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2027-09-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.